NCT00213486View on ClinicalTrials.gov

Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

December 31, 2004

Conditions
Esophageal Neoplasms
Interventions
DRUG

irinotecan

Trial Locations (1)

76031

CHU de Rouen, Rouen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT00213486 - Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial | Biotech Hunter | Biotech Hunter